Zapzyt, Acne Treatment Gel, 10% benzoyl peroxide Gel, packaged in 1 oz (28.35g) tube, Distributed by: FOCUS CONSUMER HEALTHCARE, LLC., 801 Broad St Ste 200, Chattanooga, TN 37402. NDC 71687-0011-1

Recall Insight

This FDA Drug action (record #D-0273-2025) was formally reported on March 19, 2025, with the manufacturer initiating the action on February 24, 2025. It is classified under Moderate severity (Class II), with a current status of Ongoing. Denison Pharmaceuticals, LLC is listed as the recalling firm, operating out of Lincoln, RI. Federal records indicate 642,131 tubes units are affected, a scale large enough to require multi-state distribution tracking.

The documented reason for this recall is: Chemical Contamination: Presence of benzene. Distribution data in the federal record shows the product reached: Nationwide within the USA. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.

To put this record in context, PlainRecalls indexes 83,949 recalls across the FDA, CPSC, NHTSA and USDA FSIS going back to 1995. Within the same product category, the database holds 6 closely related recalls. That clustering is a signal — repeated actions in a narrow category often indicate a systemic quality-control issue, a supplier-wide contamination, or a design defect that has propagated across product lines. This recall is roughly 1 year old; older recalls can remain relevant because many units enter resale, rental, and secondary-market channels where the original warning never reaches the end user. Always cross-check the recall number against the official agency page before relying on any summary.